Recall: D-0502-2026

Class II - Potentially Harmful

Class IIClassification

2026-04-01Initiated

OngoingStatus

Wells Pharma of Houston LLCFirm

Product

Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03

Reason

cGMP deviations.

Distribution

U.S. Nationwide.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.